STAMFORD, Conn., July 9, 2012 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A. announced today that Synapse® MU 3.0, is 2011/2012 compliant and was certified as a Complete EHR on June 28, 2012 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).
"We believe that this ONC-ATCB certification demonstrates that Fujifilm is a true player in the EHR arena," said Jim Morgan, Fujifilm's Vice President of Medical Informatics. "Synapse MU 3.0 enhances our Synapse RIS product by enabling our end users such as radiology groups to qualify for the incentives set forth by the ONC while reducing the impact on operations."
The ONC-ATCB 2011/2012 certification program tests and certifies that Complete EHRs meet all of the 2011/2012 criteria and EHR Modules meet one or more - but not all - of the criteria approved by the Secretary of Health and Human Services (HHS) for either eligible provider or hospital technology.
"CCHIT is pleased to be testing and certifying products so that companies are now able to offer these products to providers who wish to purchase and implement certified EHR technology and achieve meaningful use in time for the 2011-2012 incentives," said Karen M. Bell, M.D., M.S.S., Chair, CCHIT.
Synapse MU 3.0's certification number is CC-1112-48540-2. ONC-ATCB 2011/2012 certification conferred by CCHIT does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.
The clinical quality measures to which Synapse RIS has been certified include:
NQF0013 - Hypertension: Blood Pressure Management
NQF0024 - Youth Weight Assessment
NQF0027 - Tobacco Use Cessation
NQF0028 - Preventive Care: Tobacco Use Assessment and Cessation
NQF0038 - Childhood Immunization Status
NQF0041 - Influenza Immunization
NQF0052 - Use of Imaging Study: Low Back Pain
NQF0061 - Diabetic Patients who elevated mmhg V140/90
NQF0421 - Adult Weight Screening
The additional software Synapse MU 3.0 relied upon to demonstrate compliance includes:
Wolters Kluwer Health/ Lippincott, Williams & Williams, 5 Minute Consult
Newcrop LLC, New Crop, 10.1
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc., supplies high quality, technologically advanced, FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com and www.fujinonendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was ranked among the top 17 companies around the world granted U.S. patents in 2011, and in the year ended March 31, 2012, had global revenues of $27.8 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.
* At an exchange rate of 79 yen to the dollar.
SOURCE FUJIFILM Medical Systems U.S.A., Inc.